Back to search

Aristotle University Of Thessaloniki (AUTH)

Γονοτυπικά και φαινοτυπικά χαρακτηριστικά επιθηλιακού καρκίνου των ωοθηκών σε πρωτοπαθείς όγκους και σε θέσεις διασποράς τους

Abstract

dc:description

Epithelial ovarian cancer (OVCA) is associated with genomic alterations in BRCA1/2 and TP53 and with molecular intra-patient heterogeneity (IPH), owing to tumor – host interactions, including host anti-tumor immune response. Morphological features, i.e., tissue phenotypes, are surrogates of the underlying genomic contexture. Genomic IPH, and morphological IPH may affect the efficacy of standard or targeted therapy and the validity of common predictive markers, including pathogenic mutations in BRCA1/2. We examined matched routine paraffin tissue samples (total n: 302) from 72 treatment naïve OVCA patients who were treated with surgery and platinum-based chemotherapy. Up to 8 different tissue samples per patient were obtained from the ovaries (primary site), sites of intraperitoneal spread, and from fallopian tubes. We assessed tumor morphological subtypes as immunoreactive (IR), solid – proliferative (SD), papilloglandular (PG), and mesenchymal transition (MT); subtype load per section and per patient; and, maximal stromal tumor infiltrative lymphocyte (TIL) density values (max-TILs) among all samples per patient, ovaries and implants. NGS was applied at avg mean depth >2000X. Based on tissue mutation patterns, we distinguished tissue genotypes into no mutation (33/297 samples; 11.1%), stable (173; 58.2%) and unstable (91; 30.7%). We profiled genotypes per patient and assessed genomic heterogeneity in 69 patients with multiple informative samples. The most frequent morphological subtype was PG (n=150 samples, 51.0%), followed by MT (71, 24.1%), SD (48, 16.3%) and IR (15, 5.1%), while combinations were observed in 67/294 sections (22.8%) and IPH in 48/70 patients (68.6%). PG prevailed in ovaries (p<0.001), SD and MT in implants (p=0.023 and p<0.001, respectively). sTILs were higher in SD compared to non-SD (p=0.019) and lower in PG, respectively (p<0.001). sTIL density was higher in implants (p<0.001). Among 71 informative patients, 46 (64.8%) had pathogenic BRCA1 mutations and 15 (21.7%) had BRCA1/2 disruption. All 29 patients with tissue genomic heterogeneity (t-HET, 42%) had pathogenic BRCA1. However, t-HET was observed in 64% of patients with such mutations (p<0.001). As opposed to non-t-HET, matched tissues in t-HET shared pathogenic BRCA1 (p<0.001) but not BRCA2 and TP53. Patients with t-HET had worse outcome (log-rank p=0.048 [progression-free]; p=0.037 [overall survival]), including 12/15 patients with disrupted BRCA1/2 and 3 BRCA1 carriers with partial germline loss in tissues. Favorable prognosticators were higher max-TILs per patient (PFS, OS) and higher SD-load (PFS). Morphological and host TILs heterogeneity at different tumor sites are the rule in OVCA, while genomic heterogeneity affects a significant part of OVCA patients. Pathogenic BRCA1 mutations appear necessary but may not be sufficient for OVCA heterogeneity. Genomic heterogeneity may be associated with worse outcome, including patients with disrupted BRCA1/2, which is usually considered as a favorable marker. In BRCA1/2 carriers, the condition of the germline mutation in tissues may be related to genomic and phenotypic heterogeneity and needs to be addressed in NGS reports. A pre-operative biopsy or “one representative sample” examined per current standards does not seem adequate to decipher whether the total tumor will respond to treatment in the context of Precision Oncology.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Lakis, Sotirios
  • Λάκης, Σωτήριος

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48198

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Lakis, Sotirios; Λάκης, Σωτήριος. Γονοτυπικά και φαινοτυπικά χαρακτηριστικά επιθηλιακού καρκίνου των ωοθηκών σε πρωτοπαθείς όγκους και σε θέσεις διασποράς τους. Aristotle University Of Thessaloniki (AUTH), 2020. http://hdl.handle.net/10442/hedi/48198